Indrayani Biotech Ltd vs Ttk Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Apr 19, 2026

Key Highlights

The Latest Trading Price of Indrayani Biotech Ltd is ₹ 12.14 as of 17 Apr 15:30 . The P/E Ratio of Indrayani Biotech Ltd changed from 23.5 on March 2022 to 35.1 on March 2024 . This represents a CAGR of 14.31% over 3 yearsThe P/E Ratio of TTK Healthcare Ltd changed from 0 on March 2021 to 0 on March 2024 . This represents a CAGR of 0.0% over 4 years The Market Cap of Indrayani Biotech Ltd changed from ₹ 21.73 crore on March 2021 to ₹ 64.93 crore on March 2025 . This represents a CAGR of 24.47% over 5 yearsThe Market Cap of TTK Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Indrayani Biotech Ltd for the Dec '25 is ₹ 35.85 crore as compare to the Sep '25 revenue of ₹ 37.75 crore. This represent the decline of -5.03% The revenue of TTK Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Indrayani Biotech Ltd for the Dec '25 is ₹ 3.62 crore as compare to the Sep '25 ebitda of ₹ 4.25 crore. This represent the decline of -14.82% The ebitda of TTK Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Indrayani Biotech Ltd changed from ₹ 0.85 crore to ₹ 0.12 crore over 7 quarters. This represents a CAGR of -67.33% The net profit of TTK Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Indrayani Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of TTK Healthcare Ltd changed from 18.26 % on March 2021 to 17.3 % on March 2025 . This represents a CAGR of -1.07% over 5 years .

About Indrayani Biotech Ltd

Indrayani Biotech Limited was incorporated in 1992.
The Company came out with a public issue in 1994 to part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds.
Presently, the Company is engaged in manufacture of electric motors, generators, transformers and electricity distribution and control apparatus Technical agreements have been signed with Floral Max, Malaysia; for rose cultivation; and with B L McKenzie and Associates, New Zealand, for tissue culture.
The planting material for strawberries has been acquired from the US. The company has signed a test agreement with the Technology Transfer Offer of the University of California to obtain certified planting material from nurseries in California. IBL started exporting flowers to Holland and Dubai during 1994-95.

About TTK Healthcare Ltd

TTK Healthcare Limited, a TTK Group Company was incorporated in May 1958 as Orient Pharma and later renamed as TTK Pharma in Nov '81.
The Company is the owner of famous Woodwards Gripewater brand.
The Company operate into five main Strategic Business Units namely, Pharmaceuticals, Consumer Products, Medical Devices, Foods and Protective Devices divisions.
It is engaged into Animal Welfare Products, Consumer Products, Medical Devices, Protective Devices and Foods Businesses. In 1992, the company came out with a rights issue at a premium of Rs 35 aggregating Rs 5.81 cr to finance long-term working capital needs, normal capital expenditure, and product promotion. Products of TTK Healthcare include cardiac care systems, blood management systems, renal care systems, hospital accessories, antibiotics, Woodwards gripe water, animal medicines, etc.

FAQs for the comparison of Indrayani Biotech Ltd and TTK Healthcare Ltd

Which company has a larger market capitalization, Indrayani Biotech Ltd or TTK Healthcare Ltd?

Market cap of Indrayani Biotech Ltd is 55 Cr while Market cap of TTK Healthcare Ltd is 1,235 Cr

What are the key factors driving the stock performance of Indrayani Biotech Ltd and TTK Healthcare Ltd?

The stock performance of Indrayani Biotech Ltd and TTK Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indrayani Biotech Ltd and TTK Healthcare Ltd?

As of April 19, 2026, the Indrayani Biotech Ltd stock price is INR ₹12.14. On the other hand, TTK Healthcare Ltd stock price is INR ₹874.35.

How do dividend payouts of Indrayani Biotech Ltd and TTK Healthcare Ltd compare?

To compare the dividend payouts of Indrayani Biotech Ltd and TTK Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.